Scholarlink

<p>Oral cancer, particularly oral squamous cell carcinoma, represents a major global health challenge with high rates of morbidity and mortality. Current treatments often encounter limitations such as toxicity and drug resistance. Curcumin, a natural polyphenol derived from turmeric, has shown significant promise as a therapeutic agent due to its anti-inflammatory, antioxidant, and broad-spectrum anticancer activities. However, its clinical application has been limited by poor solubility, rapid metabolism, and low bioavailability. This review examines the potential of novel curcumin formulations developed to address these challenges in oral cancer treatment. It explores advanced delivery systems including nanoparticle-based carriers, liposomes, niosomes, and hybrid technologies that enhance bioavailability and enable targeted delivery. Additionally, the review discusses synthetic curcumin analogues that offer improved stability and potency. These innovative approaches demonstrate enhanced anticancer effects through pro-apoptotic, anti-proliferative, and anti-angiogenic mechanisms, often exhibiting synergistic activity with conventional therapies. This review aims to synthesize current evidence on the mechanisms and efficacy of these advanced curcumin-based strategies and provide future perspectives on their role as safe and effective options in oral oncology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Novel curcumin formulations for the therapy of oral cancer: a comprehensive review of mechanisms, delivery systems, and translational prospects

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月17日

查看全文
  • Sina Seyyedhamzeh,
  • Mohammad Sharif Sharifani,
  • Sevda Sadr Shokriyan,
  • Ayat Jafarova,
  • Meysam Ghanbari Saray,
  • Mohammad Amin Shirmohammadi,
  • Niloufar Shahidan,
  • Amin Jafari,
  • Zeynab Pourtaghi,
  • Negin Ghahremani,
  • Adib Biyari,
  • Amir Hossein Barjasteh,
  • Mohammad Hossein Pourhanifeh

摘要

Oral cancer, particularly oral squamous cell carcinoma, represents a major global health challenge with high rates of morbidity and mortality. Current treatments often encounter limitations such as toxicity and drug resistance. Curcumin, a natural polyphenol derived from turmeric, has shown significant promise as a therapeutic agent due to its anti-inflammatory, antioxidant, and broad-spectrum anticancer activities. However, its clinical application has been limited by poor solubility, rapid metabolism, and low bioavailability. This review examines the potential of novel curcumin formulations developed to address these challenges in oral cancer treatment. It explores advanced delivery systems including nanoparticle-based carriers, liposomes, niosomes, and hybrid technologies that enhance bioavailability and enable targeted delivery. Additionally, the review discusses synthetic curcumin analogues that offer improved stability and potency. These innovative approaches demonstrate enhanced anticancer effects through pro-apoptotic, anti-proliferative, and anti-angiogenic mechanisms, often exhibiting synergistic activity with conventional therapies. This review aims to synthesize current evidence on the mechanisms and efficacy of these advanced curcumin-based strategies and provide future perspectives on their role as safe and effective options in oral oncology.